New blood test could spot fetal chromosome issues weeks earlier
NCT ID NCT06523543
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a new, ultra-early, non-invasive test can accurately detect fetal chromosomal abnormalities using cells from the placenta. Researchers will enroll 25 pregnant women between 7 and 16 weeks of pregnancy. The goal is to develop a safer, earlier alternative to current prenatal diagnostic methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Montpellier
RECRUITINGMontpellier, France, 34295, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new care protocol aims to support pregnant women in disaster zones
- Could a hidden back tissue hold the key to pelvic pain in pregnancy?
- Pregnancy's hidden strain: measuring the Back's inner support tissue
- Home kit boosts emotional bond between parents and unborn baby
- Which folate supplement works best for Moms-to-Be?
- Epidural analgesia in labor: could it shape your Baby's future?